This announcement is a separate document:
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Related Stocks Related Stocks
Latest
05:20
Johnson & Johnson (JNJ) closed down 2.71%, with the company confirming that it has suspended external evaluations in the USA and all Varipulse pulsed field ablation (PFA) cases as of January 5. Previously, Wells Fargo & Co reported that side effects could lead to disruptions in the supply of Johnson & Johnson's ablation devices. In response, Piper Sandler Analyst Matt O’Brien believes that Johnson & Johnson's suspension is bullish for competitors Boston Scientific and Medtronic.
BSX+4.30%
05:15
The FTSE A50 futures index closed down 0.25% for consecutive night trading, reported at 12,952.000 points.
05:13
The Federal Reserve meeting minutes show that major Wall Street banks have postponed their expectations for the end of balance sheet reduction.
USD/CNY+0.07%
Statement
This page is machine-translated. Futubull tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation.